OncoMatch/Clinical Trials/NCT05820126
Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial
Is NCT05820126 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies Cold-stored platelet concentrate for hematologic malignancy.
Treatment: Cold-stored platelet concentrate — This is a pilot trial to discover the feasibility of recruiting 50 pts over the course of 12 months. The trial is testing the efficacy of using cold-stored vs. room temperature stored (current standard of care) platelets to treat bleeding in persons with hematological disorders and thrombocytopenia.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Non-Hodgkin Lymphoma
Multiple Myeloma
Myelodysplastic Syndrome
Chronic Lymphocytic Leukemia
Lab requirements
Blood counts
Moderate thrombocytopenia, platelet concentration 10-100 x109/L; Exclude if severe thrombocytopenia (platelet concentration <10 x 109/L)
Moderate thrombocytopenia, platelet concentration 10-100 x109/L; Severe thrombocytopenia (platelet concentration <10 x 109/L) [excluded]
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT05820126 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify